Statsure Diagnostic Systems, Inc. - Notification that Annual Report will be submitted late (NT 10-K)
31 Marzo 2008 - 9:04AM
Edgar (US Regulatory)
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
12b-25
Commission
File Number 000-21284
NOTIFICATION
OF LATE FILING
(Check
One): [x] Form 10-K [_] Form 11-K [_] Form 20-F [ ] Form 10-Q [_] Form N-SAR
For
Period Ended: December 31, 2007
[_]
|
Transition
Report on Form 10-K
|
[_]
|
Transition
Report on Form 20-F
|
[_]
|
Transition
Report on Form 11-K
|
[_]
|
Transition
Report on Form 10-Q
|
[_]
|
Transition
Report on Form N-SAR
|
For
the
Transition Period Ended:
Read
attached instruction sheet before preparing form. Please print or type.
Nothing
in this form shall be construed to imply that the Commission has verified any
information contained herein.
If
the
notification relates to a portion of the filing checked above, identify the
item(s) to which the notification relates:
PART
I
REGISTRANT
INFORMATION
StatSure
Diagnostic Systems, Inc.
Full
Name
of Registrant
Saliva
Diagnostic Systems, Inc.
Former
Name if Applicable
Address
of Principal Executive Office (Street and Number)
City,
State and Zip Code
PART
II
RULE
12b-25(b) AND (c)
If
the
subject report could not be filed without unreasonable effort or expense and
the
registrant seeks relief pursuant to Rule 12b-25(b), the following should be
completed. (Check box if appropriate.)
(a)
|
The
reasons described in reasonable detail in Part III of this form could
not
be eliminated without unreasonable effort or
expense;
|
(b)
|
The
subject annual report, semi-annual report, transition report on Form
10-K,
Form 20-F, Form 11-K or Form N-SAR, or portion thereof
will
be filed on or before the 15th calendar day following the prescribed
due
date; or the subject quarterly report or transition report on Form
10-Q,
or portion thereof will be filed on or before the fifth calendar day
following the prescribed due date;
and
|
[X]
(c)
|
The
accountant's statement or other exhibit required by Rule 12b-25(c)
has
been attached if applicable.
|
PART
III
NARRATIVE
State
below in reasonable detail why the Form 10-K, 11-K, 20-F 10-Q, N-SAR or the
transition report portion thereof could not be filed within the prescribed
time
period. (Attach extra sheets if needed.)
The
Form
10-KSB could not be filed timely as certain calculations required for financial
statements have taken up a significant amount of time and has affected
scheduling by our accountants. The Company expects to file within the extension
period.
PART
IV
OTHER
INFORMATION
(1)
|
Name
and telephone number of person to contact in regard to this
notification
|
Leo
Ehrlich
|
347
|
394-3641
|
(Name)
|
(Area
Code)
|
(Telephone
Number)
|
(2)
|
Have
all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period
that
the registrant was required to file such report(s) been filed? If the
answer is no, identify report(s).
|
[X]
Yes
[_] No
(3)
|
Is
it anticipated that any significant change in results of operations
from
the corresponding period for the last fiscal year will be reflected
by the
earnings statements to be included in the subject report or portion
thereof?
|
[
] Yes
[X] No
If
so:
attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
STATSURE
DIAGNOSTIC SYSTEMS, INC.
(Name
of
Registrant as Specified in Charter)
Has
caused this notification to be signed on its behalf by the undersigned thereunto
duly authorized.
Date
March 31, 2008
|
/s/Leo
Ehrlich
|
|
Leo
Ehrlich
|
|
Chief
Financial Officer
|
INSTRUCTION:
The form may be signed by an executive officer of the registrant or by any
other
duly authorized representative. The name and title of the person signing the
form shall be typed or printed beneath the signature. If the statement is signed
on behalf of the registrant by an authorized representative (other than an
executive officer), evidence of the representative's authority to sign on behalf
of the registrant shall be filed with the form.
ATTENTION
Intentional
misstatements or omissions of fact constitute Federal Criminal Violations (see
18 U.S.C. 1001).
GENERAL
INSTRUCTIONS
1.
This
form is required by Rule 12b-25 of the General Rules and
Regulations
under the Securities Exchange Act of 1934.
2.
One
signed original and four conformed copies of this form and amendments thereto
must be completed and filed with the Securities and Exchange Commission,
Washington, D.C. 20549, in accordance with Rule 0-3 of the General Rules and
Regulations under the Act. The information contained in or filed with the form
will be made a matter of public record in the Commission files.
3.
A
manually signed copy of the form and amendments thereto shall be filed with
each
national securities exchange on which any class of securities of the registrant
is registered.
4.
Amendments to the notifications must also be filed on Form 12b-25 but need
not
restate information that has been correctly furnished. The form shall be clearly
identified as an amended notification.
5.
ELECTRONIC FILERS. This form shall not be used by electronic filers unable
to
timely file a report solely due to electronic difficulties. Filers unable to
submit a report within the time period prescribed due to difficulties in
electronic filing should comply with either Rule 201 or Rule 202 of Regulation
S-T or apply for an adjustment in filing date pursuant to Rule 13(b) of
Regulation S-T.
StatSure Diagnostic Syst... (CE) (USOTC:SSUR)
Gráfica de Acción Histórica
De May 2024 a Jun 2024
StatSure Diagnostic Syst... (CE) (USOTC:SSUR)
Gráfica de Acción Histórica
De Jun 2023 a Jun 2024